{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-25-020977","form_type":"8-K","ticker":"GNPX","cik":"0001595248","company_name":"Genprex, Inc.","filed_at":"2025-06-23T23:59:59+00:00","discovered_at":"2026-05-14T18:02:48.941295+00:00","generated_at":"2026-05-18T23:43:14.318575+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Genprex reports positive preclinical data for GPX-002 using lipid nanoparticle delivery at ADA 2025","bullets":["Nine LNPs tested; two were highly efficient in transfecting α- and β-cells in isolated mouse islets.","LNP using ALX-184 with mRNA payload injected into mouse common bile duct efficiently transfected pancreatic cells.","Non-viral LNP approach could enable repeat dosing and may eliminate need for immunosuppression.","Research presented at ADA 85th Scientific Sessions in Chicago; builds on ongoing AAV-based studies.","Company views results as proof-of-concept for a next-generation diabetes gene therapy delivery system."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-25-020977","json":"https://secwatch.observer/filing/0001437749-25-020977.json","markdown":"https://secwatch.observer/filing/0001437749-25-020977.md","text":"https://secwatch.observer/filing/0001437749-25-020977.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1595248/000143774925020977/0001437749-25-020977-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1595248/000143774925020977/gnpx20250618_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-18T23:43:14.318575+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}